Collaboration Compound definition

Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).
Collaboration Compound means, for a Collaboration Program, any compound (including any peptide, protein or nucleic acid), construct, composition or biological entity directed to the Collaboration Target identified for such Collaboration Program and arising from the conduct of such Collaboration Program which meets the criteria for further Development set forth in the applicable Research Plan, and any modification, variant or derivative thereof.
Collaboration Compound means [ * ].

Examples of Collaboration Compound in a sentence

  • In the case that Novartis desires to replace any Collaboration Target in accordance Section 3.3(b) (Other Replacement), Novartis shall provide written notice to Schrӧdinger, through the JSC, of Novartis’ basis for its determination that no Collaboration Compound has met or is likely to meet the criteria set forth in the DC Criteria of such Collaboration Target (such notice, the “Proposed Replacement Notice”), and the JSC shall discuss in good faith such basis.

  • Schrӧdinger will promptly notify Novartis in the event Schrӧdinger or any of its Affiliates, or to Schrӧdinger’s knowledge any of its or their (sub)licensees, receives any such written notice from a Third Party during the Term and reasonably cooperate with Novartis in assessing and mitigating any resulting risks to a Project or to Novartis’ ability to Exploit any Collaboration Compound or Collaboration Product.

  • Without limiting the foregoing, Schrӧdinger covenants that it will not seek Patent term extensions, supplemental protection certificates, or similar rights or extensions for the Product Specific Patents or Joint Patents, or any Patent with respect to any Collaboration Compound or Collaboration Product, without the prior written consent of Novartis.

  • Novartis shall have the sole right, but not the obligation, to apply for any patent term extension, supplemental Patent certificate or related extension of rights with respect to the Product Specific Patents and Joint Patents, or any Patent with respect to any Collaboration Compound or Collaboration Product.

  • In particular, each Party will notify and provide the other Party with copies of any allegations of Patent invalidity, unenforceability or non-infringement of any Product Specific Patents or Joint Patents Covering a Collaboration Compound or Collaboration Product (including methods of use or manufacture thereof).


More Definitions of Collaboration Compound

Collaboration Compound means a Drug Candidate (and any Follow-On Compound with respect to such Drug Candidate) and/or a Future Program Compound (and any Follow-On Compound with respect to such Future Program Compound), as applicable.
Collaboration Compound means the Lead Compound and any Backup Collaboration Compound.
Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.5 and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).
Collaboration Compound means any molecule that (a) has a molecular weight less than or equal to [ * ]; (b) has the ability to inhibit, activate or otherwise modulate the activity of a Mammalian Target (other than a Confirmed Target) or its encoded protein; and (c) such ability is identified by or on behalf of BMS or its Affiliate or sublicensee through the use to any material extent of a Mammalian Target (other than a Confirmed Target) or any information relating to a Mammalian Target (other than a Confirmed Target) developed by or on behalf of BMS or its Affiliate or sublicensee by material use of such Mammalian Target, the DNA sequence relating thereto, or any other Research Results disclosed to BMS hereunder that (i) directly relate to such Mammalian Target (other than a Confirmed Target) or the Target to which such Mammalian Target is related, and (ii) Remain Confidential at the time of such use, provided that the foregoing definition is subject to the limitations in Section 4.15.
Collaboration Compound means any ADC that is generated within the Collaboration Program, as well as the antibodies incorporated in the ADC.
Collaboration Compound means Xxxxxxxxx’x proprietary compound designated by Xxxxxxxxx on the Effective Date as “HMPL-504,” as more fully described in Schedule 1.19 and as improved or modified in connection with this Agreement, [**].
Collaboration Compound means any Targacept Compound, or any salt, solvate, prodrug form, inclusion complex or metabolite thereof. For the avoidance of doubt, all Development Compounds and Back-Up Compounds shall be deemed to be Collaboration Compounds.